K. Zhang

Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease.

B. Hee, B. Potts, C. Lee, 2001, Drug metabolism and disposition: the biological fate of chemicals.

Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation.

B. Arison, J. A. Naue, K. Vyas, 1996, Chemical research in toxicology.

The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.

D. Dean, D. Melillo, G. Doss, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.

R. Chang, B. Lagu, C. Forray, 2000, Bioorganic & medicinal chemistry letters.

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.

R. Chang, P. Kling, B. Lagu, 1999, Journal of medicinal chemistry.

Metabolic chiral inversion of stiripentol in the rat. II. Influence of route of administration.

T. Baillie, C. Tang, R. Levy, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Metabolic chiral inversion of stiripentol in the rat. I. Mechanistic studies.

T. Baillie, C. Tang, R. Levy, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Metabolism of A dopamine D(4)-selective antagonist in rat, monkey, and humans: formation of A novel mercapturic acid adduct.

T. Baillie, G. Doss, M. Davis, 2000, Drug metabolism and disposition: the biological fate of chemicals.